For a copy of Par's Form 10-Q for the second quarter ended June 28, 2008, visit Investors/SEC Filings on the Par web site at http://www.parpharm.com.
Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit http://www.parpharm.com.
Safe Harbor Statement
Certain statements in this news release constitute "forward-looking
statements" within the meaning of the Private Securities Litigation Reform
Act of 1995. To the extent any statements made in this news release contain
information that is not historical, these statements are essentially
forward- looking and, as such, are subject to known and unknown risks,
uncertainties and contingencies, many of which are beyond the control of
the Company, which could cause actual results and outcomes to differ
materially from those expressed herein. Risk factors that might affect such
forward-looking statements include those set forth in Item 1A of the
Company's Annual Report on Form 10-K for the year ended December 31, 2007,
in Item 1A of the Company's subsequent Quarterly Reports on Form 10-Q, in
other of the Company's filings with the SEC from time to time, including
Current Reports on Form 8-K, and on general industry and economic
conditions. Any forward-looking statements included in this news release
are made as of the date hereof only, based on information available to the
Company as of the date hereof, and, subject to any applicable law to the
contrary, the Company assumes no obligation to update any forward-looking
PAR PHARMACEUTICAL COMPANIES, INC.
|SOURCE Par Pharmaceutical Companies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved